共 219 条
[31]
Li C-P(2015)Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis World J Gastroenterol 21 2807-916
[32]
Bodoky G(2020)Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19–9 in estimating survival in patients with metastatic pancreatic cancer J Cancer Res Ther. 16 909-994
[33]
Demols A(2010)Application of a time-varying covariate model to the analysis of CA 19–9 as serum biomarker in patients with advanced pancreatic cancer Clin Cancer Res 16 986-143
[34]
Peeters M(2020)Analysis of clinical predictive factors affecting the outcome of second-line chemotherapy for gemcitabine-refractory advanced pancreatic cancer Gut Liver 14 135-194
[35]
Polus M(2017)Overall survival prediction and usefulness of second-line chemotherapy in advanced pancreatic adenocarcinoma J Natl Cancer Inst. 109 10-undefined
[36]
Marechal R(2016)Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer [published correction appears in Br J Cancer. 2016 Oct25; 115(9):e13] Br J Cancer. 115 188-undefined
[37]
Gay F(undefined)undefined undefined undefined undefined-undefined
[38]
Monsaert E(undefined)undefined undefined undefined undefined-undefined
[39]
Hendlisz A(undefined)undefined undefined undefined undefined-undefined
[40]
Van Laethem JL(undefined)undefined undefined undefined undefined-undefined